Decision Intelligence Applications

Products built on
biological truth.

Every EQAI product is an application layer on top of the Foundation Intelligence stack. From genetic health screening to full-chain traceability — each output is evidence-grounded, version-controlled, and 100% traceable to source data.

5 Products
14 Validated Variants
79 Diseases Tracked
100% Evidence-Linked

Layer 4: Decision Intelligence Applications

Built on Foundation Intelligence. Designed for real-world equine decisions.

Layer 1 Corporate Brand — EQAI Identity
Layer 2 Platform — Dashboard, API, SDK Experience
Layer 3 Core Engines — HorseVector · Knowledge Graph · Foundation Model Intelligence
Layer 4 Applications — JumpHealth™ · JumpID™ · JumpChain™ · DMRT3™ · MSTN Pro™ You are here
Health Intelligence

JumpHealth

Genetic disease screening report — identifying risk factors across 79 diseases with 14 validated pathogenic variants, TIER-classified evidence, and 100% source traceability.

  • 14 pathogenic variants — each validated with rsID, OMIA identifier, and peer-reviewed source literature
  • TIER evidence classification — Tier A (validated, high-confidence) through Tier C (emerging evidence), honestly labeled
  • 100% source traceability — every data point links to source paper, sample ID, and genomic coordinate
  • Breed-specific interpretation — variant frequency data across 17 genotyped breeds for contextualized results
  • Human expert review — every report reviewed by veterinary geneticist before delivery
JumpHealth™ Report #JH-2026-04821 Validated
Subject EQ-00482-Thoroughbred
Breed Thoroughbred
Variants Screened 14 / 14
HYPP (N/C) TIER A
HERDA (N/C) TIER A
GBED (GYS2) TIER A
MH (MYOT) TIER B
Evidence Version v3.4 · 2026-07-08
Confidence 98.7% coord. consistency
Identity & Pedigree

JumpID

DNA-based identity confirmation and pedigree registration — establishing verifiable biological identity for every equine.

  • DNA identity confirmation — unique genetic fingerprint derived from genome-wide SNP panel
  • Pedigree verification — parentage testing with statistical confidence intervals
  • Breed registry integration — structured data output compatible with international breed registries
  • Breed composition analysis — genetic ancestry estimation across 17+ reference populations
JumpID™ Certificate Confirmed
DNA ID EQ-DNA-7F3A92B
Name Stellar Wind
Breed Arabian
Sex Mare
Sire Verified ✓ Confirmed (99.97%)
Dam Verified ✓ Confirmed (99.99%)
SNP Markers 96-locus panel
ISCAG Compatible ✓ Yes
Full-Chain Traceability

JumpChain

Sample-to-report data traceability chain — every step auditable, every result verifiable, every decision grounded in provenance.

  • End-to-end chain of custody — from sample collection through laboratory processing to final report
  • Cryptographic verification — each step sealed with tamper-evident hash chain
  • Timestamped audit trail — every processing step logged with operator, time, and parameters
  • Regulatory compliance ready — designed for ISO 17025 lab accreditation requirements
01
Sample Collection
2026-06-15T09:23:17Z · Hair follicle · Operator: Dr. Chen
02
DNA Extraction
2026-06-15T14:05:42Z · Yield: 2.4μg · Purity: A260/280=1.89
03
Genome Sequencing
2026-06-16T08:11:03Z · Illumina NovaSeq · 30x coverage · Q30 > 95%
04
Variant Calling
2026-06-16T16:45:28Z · EQAI Pipeline v3.4 · 4.2M variants detected
05
Report Generation
2026-06-17T10:22:51Z · Hash: 7f3a92b... · Sealed ✓
Performance Genetics

骏快-DMRT3

Gait gene rapid test — DMRT3 "gait keeper" gene variant analysis for understanding locomotion genetics in equine.

  • DMRT3 gene association analysis — the "gait keeper" mutation (c.1174G>A) linked to lateral gait ability
  • Three-genotype classification — AA (gaited), CA (intermediate), CC (non-gaited) with breed-contextualized interpretation
  • Rapid turnaround — targeted genotyping with results in 48 hours from sample receipt
  • Cross-breed validated — evidence from Icelandic Horse, Tennessee Walking Horse, Paso Fino, and more
DMRT3 Chr12:27,816,684
Variant c.1174G>A (p.Glu391Arg)
rsID rs113092718
Function Gait keeper — spinal cord interneuron development
A/A
Homozygous gaited
C/A
Heterozygous
C/C
Non-gaited
Speed Genetics

骏快-MSTN Pro

Speed gene analysis — MSTN (myostatin) gene genotyping for understanding muscle development genetics and sprint vs. stamina predisposition.

  • MSTN gene genotyping — the "speed gene" (g.66493737C>T) associated with muscle fiber type composition
  • Speed-stamina spectrum — C/C (speed), C/T (middle-distance), T/T (stamina) classification
  • Thoroughbred-validated — robust evidence from racing performance studies across multiple populations
  • Breed-frequency context — allele frequency data across breeds for meaningful result interpretation
MSTN Chr11:66,493,737
Variant g.66493737C>T (BIEC2-66493737)
rsID rs105006161
Function Myostatin — muscle growth regulation
C/C
Speed type
C/T
Middle-distance
T/T
Stamina type

Product overview

Five products, one foundation. Each application leverages the same validated biological intelligence layer — with different output formats and delivery channels.

Product Primary Function Target Users Delivery Turnaround API Access
JumpHealth™ Genetic disease screening (79 diseases, 14 variants) Breeders, Veterinarians Digital Report + PDF 5–7 business days
JumpID™ DNA identity confirmation & pedigree verification Registries, Breeders Certificate + Data File 3–5 business days
JumpChain™ Sample-to-report full-chain auditability Labs, Regulators Audit Trail + Verification API Real-time
骏快-DMRT3™ Gait gene (DMRT3) variant analysis Breeders, Trainers Rapid Report 48 hours
骏快-MSTN Pro™ Speed gene (MSTN) genotyping Breeders, Trainers, Racing Rapid Report 48 hours

Important Notice — Regulatory & Scientific Disclaimer

JumpHealth™ identifies genetic risk factors. It is not a diagnosis. EQAI products provide biological intelligence based on current scientific evidence. They do not replace professional veterinary judgment. Clinical decisions should always be made in consultation with a licensed veterinarian.

Biology is probabilistic. We provide evidence, not certainties. Genetic test results indicate risk factors and associations — they do not guarantee outcomes. Phenotype expression depends on complex interactions between genetics, environment, management, and other factors not captured by genetic screening alone.

Every claim is traceable. Every limitation is disclosed. When evidence is insufficient, we say "Insufficient evidence" — we never generate plausible-sounding guesses. All AI-generated outputs are flagged. No synthetic biological data is ever presented as real evidence. Evidence quality is classified using our TIER system (A/B/C) so users can assess confidence independently.

Breeding decisions involve more than genetics. EQAI provides genetic information. Breeding decisions involve economics, ethics, breed standards, and breeder judgment. We inform — we do not prescribe.

From genome to decision.
Decode to Decide.

Request access to the EQAI platform. Explore our products, review our evidence model, and see how biological intelligence can inform your equine decisions.